Gene transfer into hematopoietic stem cells (HSCs) has the potential to treat many diseases, including hemoglobinopathies, immunodeficiencies, infectious diseases, and even disorders of other organ systems if HSCs form different tissue types. However the oncogenic risks of insertional mutagenesis and low transduction rates of human HSCs remain major problems. Here we propose to develop retroviral vectors based on foamy virus (FV) in order to overcome these problems. Wild-type FV is a non-pathogenic virus common in captive primates that has never been linked to oncogenesis, suggesting that FV vectors may be safer than other integrating vectors. In order to establish their oncogenic risk, we will study insertional mutagenesis by FV vectors in a variety of ways, including mapping of integration sites in human CD34+ cells; correlating provirus sites with chromosomal gene location, expression, and conformation; and determining if and how neighboring genes are activated in a panel of cells with mapped proviruses. Several assays will be developed to look at a vector s potential for activating neighboring genes, including plasmid transfection assays with cloned proviruses; celt transformation assays based on provirus-dependent activation of cytokine independence; and bone marrow transplantation assays in cancer-prone mice to directly demonstrate oncogenesis. These assays will be used to compare different FV vectors and also vectors based on lentiviruses and murine leukemia viruses. Safer FV Vectors will be designed that have less potential for activating neighboring genes by incorporating internal promoters with less enhancer activity, changing vector backbone elements to prevent read-through transcription and splicing, and including genetic insulator elements. In prior work we showed that FV vectors efficiently transform mouse and human HSCs in animal transplantation and xenotransplantation models, suggesting that they may be superior to other types of stem cell vectors. Here we will determine HSC transduction rates in large animal models that more closely simulate human hematopoiesis (dog and non-human primate). FV vectors will be compared to tentivirus and murine leukemia virus vectors in these transplantation studies to determine which vector type is more effective, and to compare potential side effects. These studies will establish useful methods for assessing the risks of any integrating vector, improve existing FV vectors, and direcdy compare the safety and efficacy of all 3 types of retroviral vectors.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL053750-12
Application #
7124272
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
2005-09-01
Budget End
2006-08-31
Support Year
12
Fiscal Year
2005
Total Cost
$312,766
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Constantinou, Varnavas C; Bouinta, Asimina; Karponi, Garyfalia et al. (2017) Poor stem cell harvest may not always be related to poor mobilization: lessons gained from a mobilization study in patients with ?-thalassemia major. Transfusion 57:1031-1039
Gori, Jennifer L; Butler, Jason M; Kunar, Balvir et al. (2017) Endothelial Cells Promote Expansion of Long-Term Engrafting Marrow Hematopoietic Stem and Progenitor Cells in Primates. Stem Cells Transl Med 6:864-876
Psatha, Nikoletta; Karponi, Garyfalia; Yannaki, Evangelia (2016) Optimizing autologous cell grafts to improve stem cell gene therapy. Exp Hematol 44:528-39
Li, Li B; Ma, Chao; Awong, Geneve et al. (2016) Silent IL2RG Gene Editing in Human Pluripotent Stem Cells. Mol Ther 24:582-91
Liu, Mingdong; Maurano, Matthew T; Wang, Hao et al. (2015) Genomic discovery of potent chromatin insulators for human gene therapy. Nat Biotechnol 33:198-203
Polak, Paz; Karli?, Rosa; Koren, Amnon et al. (2015) Cell-of-origin chromatin organization shapes the mutational landscape of cancer. Nature 518:360-364
Karponi, Garyfalia; Psatha, Nikoletta; Lederer, Carsten Werner et al. (2015) Plerixafor+G-CSF-mobilized CD34+ cells represent an optimal graft source for thalassemia gene therapy. Blood 126:616-9
Vierstra, Jeff; Reik, Andreas; Chang, Kai-Hsin et al. (2015) Functional footprinting of regulatory DNA. Nat Methods 12:927-30
Qi, Heyuan; Liu, Mingdong; Emery, David W et al. (2015) Functional validation of a constitutive autonomous silencer element. PLoS One 10:e0124588
Watts, Korashon L; Beard, Brian C; Wood, Brent L et al. (2014) No evidence of clonal dominance after transplant of HOXB4-expanded cord blood cells in a nonhuman primate model. Exp Hematol 42:497-504

Showing the most recent 10 out of 161 publications